REGINA NICHOLSON: Open Payments
NPI 1891274809 · MIDLOTHIAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 39 payments from 16 companies in 2025. Trend: 2023 $405 · 2024 $243 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 4 | $175 |
| ABBVIE INC. | 8 | $155 |
| Galderma Laboratories, L.P. | 8 | $140 |
| Kerecis Limited | 1 | $78 |
| Almirall LLC | 3 | $72 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $50 |
| Journey Medical Corporation | 2 | $37 |
| STRATA Skin Sciences, Inc. | 2 | $27 |
| Incyte Corporation | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $25 |
Products named: Zoryve, NEMLUVIO, RINVOQ, Kerecis SurgiClose, SKYRIZI, Klisyri, Clindacin ETZ, XTRAC.
Industry payments across TX — which companies pay providers there.
